In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp.

Telavancin is a new semisynthetic glycopeptide anti-infective with multiple mechanisms of action, including inhibition of bacterial membrane phospholipid synthesis and inhibition of bacterial cell wall synthesis. We determined the in vitro activities of telavancin, vancomycin, daptomycin, linezolid,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goldstein, Ellie J. C., Citron, Diane M., Merriam, C. Vreni, Warren, Yumi A., Tyrrell, Kerin L., Fernandez, Helen T.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2004
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC415607/
https://ncbi.nlm.nih.gov/pubmed/15155214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.6.2149-2152.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares